Company profile
Claris Biotherapeutics company profile
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
Business identity
- Website
- https://clarisbio.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Jersey City, New Jersey, United States
- Country code
- US
- Continent
- North America